Issues in genetic testing for ultra-rare diseases: background and introduction.
Since 1994, at least three national advisory committees have addressed issues involving access to high-quality genetic testing for ultra-rare genetic diseases. These included the Institute of Medicine (1994), a National Institutes of Health-Department of Energy Task Force on Genetic Testing (1997), and the Secretary's Advisory Committee on Genetic Testing (2000). All identified the limited availability of high-quality testing for these rare diseases as a very high priority and a number of recommendations to improve access were made. However, little systematic progress was made as a direct result of these committee recommendations. Beginning in 2004, a series of national workshops on "Quality Laboratory Testing for Rare Diseases" was organized by a group of clinical laboratory directors experienced in rare disease testing working with the Centers for Disease Control and the Office of Rare Diseases at National Institutes of Health. These meetings included broad-based community involvement, with stakeholders from appropriate federal agencies, professional societies, patient advocacy groups as well as clinical geneticists and clinical genetics laboratory experts. Two successful outcomes of these workshops were the formation of a National Laboratory Network for Rare Disease Testing and a National Institutes of Health-funded program to aid in the translation of new genetic tests from research laboratories to Clinical Laboratory Improvement Amendments-certified diagnostic laboratories known as the Collaboration and Education in Test Translation program. This article briefly reviews the history and current status of genetic testing for ultra-rare genetic diseases in the United States, with a primary focus on molecular genetic testing by DNA sequencing. Other articles in this series provide more detailed reports on the significant progress in improving access to quality genetic testing for rare diseases within the last few years.
Ledbetter
David H
DH
Department of Human Genetics, Emory University, Atlanta, Georgia 30322, USA. dledbetter@genetics.emory.edu
Faucett
W Andrew
WA
D030342:Genetic Diseases, Inborn / Q000175:diagnosis*; D033142:Genetic Services / Q000639:trends*; D006801:Humans; D007755:Laboratories, Hospital / Q000639:trends; D035583:Rare Diseases / Q000175:diagnosis*; D017422:Sequence Analysis, DNA / Q000379:methods; D014481:United States; D000078329:Workforce